Substance P is required for the pathogenesis of EMCV infection in mice.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Clinical and Experimental Medicine

• Publication date

  2009-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 19436834PMCID PMC2680056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chagas heart disease pathogenesis: one mechanism or many?

  2008cited by this paper
• Focal Adhesion Kinase as a RhoA-activable Signaling Scaffold Mediating Akt Activation and Cardiomyocyte Protection*

  2008cited by this paper
• Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex‐vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV‐infected macaques

  2008cited by this paper
• Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury.

  2007cited by this paper
• French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis.

  2007influential reference
• SUBSTANCE P IS ASSOCIATED WITH HEART ENLARGEMENT AND APOPTOSIS IN MURINE DILATED CARDIOMYOPATHY INDUCED BY TAENIA CRASSICEPS INFECTION

  2007cited by this paper
• Impaired expression of cardiac adiponectin in leptin-deficient mice with viral myocarditis.

  2006cited by this paper
• Neurogenic inflammation in acute pancreatitis.

  2005cited by this paper
• Roles of Tumor Necrosis Factor Alpha (TNF-α) and the p55 TNF Receptor in CD1d Induction and Coxsackievirus B3-Induced Myocarditis

  2005cited by this paper
• Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.

  2005influential reference
• Adiponectin Replacement Therapy Attenuates Myocardial Damage in Leptin-deficient Mice with Viral Myocarditis

  2005influential reference
• Regulation of picornavirus gene expression.

  2004cited by this paper
• Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression.

  2004cited by this paper
• Myocarditis, Microbes and Autoimmunity

  2004cited by this paper
• Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits

  2004cited by this paper
• Microbes and Autoimmunity

  2004cited by this paper
• Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis.

  2004cited by this paper
• Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis.

  2003cited by this paper
• The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection.

  2003cited by this paper
• Cardiac failure following group A streptococcal infection with echocardiographically proven pericarditis, still insufficient arguments for acute rheumatic fever: a case report and literature update.

  2003cited by this paper
• Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice.

  2003influential reference
• [Influenza myocarditis--pathophysiology and developmental mechanism of myocarditis].

  2003cited by this paper
• Coxsackievirus experimental heart diseases.

  2003cited by this paper
• Cocaine enhances myocarditis induced by encephalomyocarditis virus in murine model.

  2002cited by this paper
• Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells.

  2002cited by this paper
• Substance P and calcitonin gene-related peptide increase IL-1β, IL-6 and TNFα secretion from human peripheral blood mononuclear cells

  2002cited by this paper
• Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis.

  2002cited by this paper
• HIV enhances substance P expression in human immune cells

  2002cited by this paper
• Rheumatic fever

  2001cited by this paper
• Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha.

  2001cited by this paper
• Substance P enhances HIV-1 replication in latently infected human immune cells.

  2001cited by this paper
• Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha.

  2001cited by this paper
• The Neuropeptide Substance P Activates p38 Mitogen-Activated Protein Kinase Resulting in IL-6 Expression Independently from NF-κB1

  2000cited by this paper
• Therapy with the nonpeptide endothelin receptor antagonist 97-139 in a murine model of congestive heart failure: reduction of cardiac mass and myofiber hypertrophy.

  2000influential reference
• Analysis of the inflammatory response induced by substance P in the mouse pleural cavity.

  1999cited by this paper
• Increased severity of viral myocarditis in mice lacking lymphocyte maturation.

  1999influential reference
• Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line.

  1999cited by this paper
• Substance P and Histamine Induce Interleukin‐6 Expression in Human Astrocytoma Cells by a Mechanism Involving Protein Kinase C and Nuclear Factor‐IL‐6

  1998cited by this paper
• Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization.

  1998cited by this paper
• Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells.

  1997cited by this paper
• Tumor Necrosis Factor-α Provokes a Hypertrophic Growth Response in Adult Cardiac Myocytes

  1997cited by this paper
• Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.

  1997cited by this paper
• Human monocytes and macrophages express substance P and neurokinin-1 receptor.

  1997cited by this paper
• Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes.

  1997cited by this paper
• Calcium channel blocker-induced protection against cardiovascular damage.

  1997cited by this paper
• Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production.

  1997cited by this paper
• Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α

  1997cited by this paper
• Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

  1996cited by this paper
• Persistent expression of cytokine in the chronic stage of viral myocarditis in mice.

  1996cited by this paper
• Modification of viral myocarditis in mice by interleukin-6.

  1996cited by this paper
• Stimulation of atrial natriuretic peptide release by neurokinins in neonatal rat ventricular cardiomyocytes.

  1996cited by this paper
• Variation in serum creatine phosphokinase activity as indicated in two-phase EMC-D virus-induced myocarditis.

  1996influential reference
• Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.

  1995influential reference
• Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor.

  1994cited by this paper
• Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin.

  1993cited by this paper
• Stimulation of the chemotactic migration of human fibroblasts by substance P.

  1993cited by this paper
• Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling.

  1993cited by this paper
• Pharmacotherapy of dilated cardiomyopathy: Current status and future directions

  1992influential reference
• Lessons from animal experiments in myocarditis.

  1992influential reference
• Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

  1989cited by this paper
• Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus.

  1987cited by this paper
• [Viral myocarditis (the etiologic, clinical, diagnostic and treatment problems)].

  1985cited by this paper
• [Viral myocarditis (the etiologic, clinical, diagnostic and treatment problems)].

  1985cited by this paper
• An Animal Model of Congestive (Dilated) Cardiomyopathy: Dilatation and Hypertrophy of the Heart in the Chronic Stage in DBA/2 Mice with Myocarditis Caused by Encephalomyocarditis Virus

  1982influential reference
• Dilated Cardiomyopathy in Transgenic Mice with Cardiac-specific Overexpression of Tumor Necrosis Factor-α Kubota Et Al Is Tumor Necrosis Factor-α Friend or Foe for Chronic Heart Failure? Circulation Research Classics

  year unknowncited by this paper

• Neurokinin-1 Receptor Regulation of Fibroblast Phenotype and Function

  2025cites this paper
• Cellular Metabolism of Substance P Produces Neurokinin-1 Receptor Peptide Agonists with diminished cyclic AMP Signaling.

  2024cites this paper
• The Src1-PGC1α-AP1 complex-dependent secretion of substance P induces inflammation and apoptosis in encephalomyocarditis virus-infected mice.

  2023cites this paper
• The neuropeptide substance P/neurokinin‐1 receptor system and diabetes: From mechanism to therapy

  2023cites this paper
• Management of encephalomyocarditis virus infection in Italian pig farms: a case report

  2023cites this paper
• Changes in Substance P and Calcitonin Gene-Related Peptide Serum Levels in COVID-19 Patients- For Better Understanding of Disease Biology

  2022cites this paper
• Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity

  2021cites this paper
• Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?

  2021cites this paper
• Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype Changes

  2021cites this paper
• Substance P prevents doxorubicin-induced cardiomyocyte injury by regulating apoptosis and autophagy: In vitro and in vivo evidence

  2021cites this paper
• Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment

  2021cites this paper
• Histamine receptors in heart failure

  2021cites this paper
• Neurogenic inflammation in fulminant myocarditis: May be a trigger.

  2020cites this paper
• SARS-Corona Virus-2 May Initially Infect Brainstem through Trigeminal Ganglion-Latency May Be Present-A New Perspective

  2020cites this paper
• ผลของสารสกัดเหง้าไพลต่อการยับยั้งการแสดงออกของยีนทีเอซีวันที่ควบคุมการ สร้างซับสแตนพี ในเนื้อเยื่อในฟันมนุษย์ INHIBITORY ACTIVITY OF Zingiber cassumunar Roxb. RHIZOME EXTRACT ON TAC-1 SUBSTANCE P GENE IN HUMAN DENTAL PULP CELLS

  2020cites this paper
• In Silico Guided Drug Repurposing to Combat SARS-CoV-2 by Targeting Mpro, the Key Virus Specific Protease

  2020cites this paper
• Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children – a mystery so far. New insight into the role of Substance P

  2020cites this paper
• Neurokinin receptor antagonism: a patent review (2014-present)

  2020cites this paper
• Substance P-mediated cardiac mast cell activation: An in vitro study.

  2019cites this paper
• Anthracycline-Induced Cardiotoxicity: Time to Focus on Cardioprotection Again.

  2019cites this paper
• The involvement of the substance P/neurokinin 1 receptor system in viral infection: focus on the gp120 fusion protein and homologous dipeptide domains.

  2019influential citation
• Substance P in cardiovascular diseases - A bioanalytical review.

  2019cites this paper
• Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts.

  2019cites this paper
• Understanding the Complex Roles of Substance P in the Diseased Heart.

  2018cites this paper
• Substance P and its role in viral infection

  2018cites this paper
• Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis

  2017cites this paper
• Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P

  2017cites this paper
• The role of neuropeptides in adverse myocardial remodeling and heart failure

  2017cites this paper
• The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders

  2017cites this paper
• Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance

  2016cites this paper
• Role of substance P in the cardiovascular system.

  2016cites this paper
• Substance P prevents 1-methyl-4-phenylpyridinium-induced cytotoxicity through inhibition of apoptosis via neurokinin-1 receptors in MES23.5 cells.

  2015cites this paper
• Biological and Pharmacological Aspects of the NK1-Receptor

  2015cites this paper
• Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis

  2015cites this paper
• Role of neuropeptides in cardiomyopathies.

  2014cites this paper
• The Cardio-Protective Effects of Substance P in Both Ischemia/Reperfusion and and Short-Term Hypoxia Rat Models

  2014cites this paper
• Involvement of substance P and the NK-1 receptor in human pathology

  2014influential citation
• Substance P in heart failure: the good and the bad.

  2014cites this paper
• Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension.

  2013cites this paper
• Cardiac-Specific Overexpression of Melanoma Differentiation–Associated Gene-5 Protects Mice From Lethal Viral Myocarditis

  2013cites this paper
• Progress in the study on models for viral myocarditis

  2013cites this paper
• Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations.

  2011cites this paper
• Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.

  2011cites this paper
• Neurokinin‐1 receptor: functional significance in the immune system in reference to selected infections and inflammation

  2011cites this paper
• NK-1 receptor antagonists: a new paradigm in pharmacological therapy.

  2011cites this paper
• LITHUANIAN UNIVERSITY OF HEALTH SCIENCES MEDICAL ACADEMY

  2011cites this paper
• Role of substance P in viral myocarditis in mice

  2010cites this paper